IBRX
NASDAQ · Biotechnology
Immunitybio Inc
$7.32
+0.10 (+1.39%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+242.06%
1Y
+162.37%
YTD
+262.38%
Open$7.05
Previous Close$7.22
Day High$7.60
Day Low$7.00
52W High$12.43
52W Low$1.95
Volume—
Avg Volume11.32M
Market Cap7.71B
P/E Ratio—
EPS$-0.85
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$4.22
Above
SMA 200
$2.95
Above
RSI (14)
70.9
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,386.2% upside
Current
$7.32
$7.32
Target
$108.79
$108.79
$71.54
$108.79 avg
$142.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 129.03M | 1.55B | 1.61B |
| Net Income | -400,089,225 | 174.18M | 206.87M |
| Profit Margin | -310.2% | 11.2% | 12.9% |
| EBITDA | -273,883,069 | 310.76M | 319.11M |
| Free Cash Flow | — | 125.72M | 219.44M |
| Rev Growth | +678.6% | +14.4% | +15.1% |
| Debt/Equity | 0.01 | 0.68 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |